{
  "id": "57070279fcca4801",
  "title": "Moderna Shares Jump After FDA Agrees To Review Flu Vaccine",
  "description": "20260218T170000Z",
  "content": "",
  "source": "forbes.com",
  "source_url": "https://www.forbes.com/sites/tylerroush/2026/02/18/moderna-shares-rally-6-after-fda-reverses-decision-not-to-review-flu-vaccine/",
  "published_at": "20260218T170000Z",
  "fetched_at": "2026-02-19T00:30:34.211663+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.forbes.com/sites/tylerroush/2026/02/18/moderna-shares-rally-6-after-fda-reverses-decision-not-to-review-flu-vaccine/",
    "url_mobile": "",
    "title": "Moderna Shares Jump After FDA Agrees To Review Flu Vaccine",
    "seendate": "20260218T170000Z",
    "socialimage": "https://imageio.forbes.com/specials-images/imageserve/6995de98cd1bd9b2194818f3/0x0.jpg?format=jpg&crop=3181,1791,x0,y0,safe&fit=bounds",
    "domain": "forbes.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}